BioSilta and Sigma-Aldrich Sign Global Distribution Agreement

News   Oct 14, 2014

 
BioSilta and Sigma-Aldrich Sign Global Distribution Agreement
 
 
 

RELATED ARTICLES

Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News

A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.

READ MORE

Protein "Intentionally" Terminates own Synthesis by Destabilizing Synthesis Machinery — the Ribosome

News

A research group has discovered that a protein, during its synthesis, may destabilize the structure of the ribosome and end its own synthesis prematurely, and found that this phenomenon is used for adapting the cell to its environment.

READ MORE

New Simple Test Could Help Cystic Fibrosis Patients Find Best Treatment

News

In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique shows promise as a fast, inexpensive indicator to help more patients access new treatments.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE